Matthew Stuart McKinney, MD

Assistant Professor of Medicine
Campus mail 101 Science Drive, 2195A CIEMAS, Durham, NC 27710
Phone (919) 684-8111
Email address matthew.mckinney@duke.edu

Education and Training

  • Fellowship, Hematology / Oncology, Duke University School of Medicine, 2010 - 2013
  • Residency, General Internal Medicine, Duke University School of Medicine, 2006 - 2009
  • M.D., Duke University, 2006

Publications

Moffitt, AB, Ondrejka, SL, McKinney, M, Rempel, RE, Goodlad, JR, Teh, CH, Leppa, S, Mannisto, S, Kovanen, PE, Tse, E, Au-Yeung, RKH, Kwong, Y-L, Srivastava, G, Iqbal, J, Yu, J, Naresh, K, Villa, D, Gascoyne, RD, Said, J, Czader, MB, Chadburn, A, Richards, KL, Rajagopalan, D, Davis, NS, Smith, EC, Palus, BC, Tzeng, TJ, Healy, JA, Lugar, PL, Datta, J, Love, C, Levy, S, Dunson, DB, Zhuang, Y, Hsi, ED, and Dave, SS. "Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2." The Journal of experimental medicine 214, no. 5 (May 2017): 1371-1386.

PMID
28424246
Full Text

McKinney, M, Moffitt, AB, Gaulard, P, Travert, M, De Leval, L, Nicolae, A, Raffeld, M, Jaffe, ES, Pittaluga, S, Xi, L, Heavican, T, Iqbal, J, Belhadj, K, Delfau-Larue, MH, Fataccioli, V, Czader, MB, Lossos, IS, Chapman-Fredricks, JR, Richards, KL, Fedoriw, Y, Ondrejka, SL, Hsi, ED, Low, L, Weisenburger, D, Chan, WC, Mehta-Shah, N, Horwitz, S, Bernal-Mizrachi, L, Flowers, CR, Beaven, AW, Parihar, M, Baseggio, L, Parrens, M, Moreau, A, Sujobert, P, Pilichowska, M, Evens, AM, and Chadburn, A et al. "The Genetic Basis of Hepatosplenic T-cell Lymphoma." Cancer discovery 7, no. 4 (April 2017): 369-379.

PMID
28122867
Full Text

Healy, JA, Nugent, A, Rempel, RE, Moffitt, AB, Davis, NS, Jiang, X, Shingleton, JR, Zhang, J, Love, C, Datta, J, McKinney, ME, Tzeng, TJ, Wettschureck, N, Offermanns, S, Walzer, KA, Chi, J-T, Rasheed, SAK, Casey, PJ, Lossos, IS, and Dave, SS. "GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo." Blood 127, no. 22 (June 2016): 2723-2731.

PMID
26989201
Full Text

Papalas, JA, McKinney, MS, Kulbacki, E, Dave, SS, and Wang, E. "Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma." The American Journal of dermatopathology 36, no. 2 (February 2014): 148-152.

PMID
24556900
Full Text

Walsh, K, McKinney, MS, Love, C, Liu, Q, Fan, A, Patel, A, Smith, J, Beaven, A, Jima, DD, and Dave, SS. "PAK1 mediates resistance to PI3K inhibition in lymphomas." Clinical cancer research : an official journal of the American Association for Cancer Research 19, no. 5 (March 2013): 1106-1115.

PMID
23300274
Full Text

Love, C, Sun, Z, Jima, D, Li, G, Zhang, J, Miles, R, Richards, KL, Dunphy, CH, Choi, WWL, Srivastava, G, Lugar, PL, Rizzieri, DA, Lagoo, AS, Bernal-Mizrachi, L, Mann, KP, Flowers, CR, Naresh, KN, Evens, AM, Chadburn, A, Gordon, LI, Czader, MB, Gill, JI, Hsi, ED, Greenough, A, Moffitt, AB, McKinney, M, Banerjee, A, Grubor, V, Levy, S, Dunson, DB, and Dave, SS. "The genetic landscape of mutations in Burkitt lymphoma." Nature genetics 44, no. 12 (December 2012): 1321-1325.

PMID
23143597
Full Text

Morse, MA, Hobeika, A, Serra, D, Aird, K, McKinney, M, Aldrich, A, Clay, T, Mourich, D, Lyerly, HK, Iversen, PL, and Devi, GR. "Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function." Cancer Gene Ther 19, no. 1 (January 2012): 30-37.

PMID
21997230
Full Text

McKinney, M, and Arcasoy, MO. "Erythropoietin for oncology supportive care." Exp Cell Res 317, no. 9 (May 15, 2011): 1246-1254. (Review)

PMID
21396935
Full Text

McKinney, MS, and Crawford, J. "Erythropoiesis-stimulating agents in older adults with cancer." In Practical Geriatric Oncology, 338-350. January 1, 2010.

Full Text

Osada, T, Woo, CY, McKinney, M, Yang, XY, Lei, G, Labreche, HG, Hartman, ZC, Niedzwiecki, D, Chao, N, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine." Clin Cancer Res 15, no. 8 (April 15, 2009): 2789-2796.

PMID
19351755
Full Text

Pages